论文信息 - Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study. - 字舞流文

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study.

F. Albers | M. Humbert | E. Bel | S. Korn | G. Brusselle | M. Masoli | E. Bradford | S. Khurana | J. FitzGerald | Motokazu Kato | M. Gilson | R. Price | J. FitzGerald